MYC and cancer: Consistently, FOXM1 knockdown downregulated the expression levels of cancer stem cell markers SOX2, c-Myc and Nanog, and reduced the mammosphere formation capacity and the CD44hi/CD24lo population in MDA-MB-231 cells (Figures 2g–i).